DK1728507T3 - Anvendelse af vitamin K for at omvende forkalkning af blodkar - Google Patents

Anvendelse af vitamin K for at omvende forkalkning af blodkar

Info

Publication number: DK1728507T3
Authority: DK; Denmark
Prior art keywords: vitamin; blood vessel; failure; cardiovascular disorders; left ventricular
Prior art date: 2005-06-03

Application number

DK06076172.3T

Other languages

English (en)

Other versions

DK1728507T4 (da

Inventor

Cees Vermeer

Original Assignee

Nattopharma Asa

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2005-06-03

Filing date

2006-06-06

Publication date

2011-05-23

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=36940251&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1728507(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2005-06-03 Priority claimed from US11/144,853 external-priority patent/US9364447B2/en

2006-06-06 Application filed by Nattopharma Asa filed Critical Nattopharma Asa

2011-05-23 Publication of DK1728507T3 publication Critical patent/DK1728507T3/da

2015-01-12 Application granted granted Critical

2015-01-12 Publication of DK1728507T4 publication Critical patent/DK1728507T4/da

Links

229930003448 Vitamin K Natural products 0.000 title abstract 4
SHUZOJHMOBOZST-UHFFFAOYSA-N phylloquinone Natural products CC(C)CCCCC(C)CCC(C)CCCC(=CCC1=C(C)C(=O)c2ccccc2C1=O)C SHUZOJHMOBOZST-UHFFFAOYSA-N 0.000 title abstract 4
235000019168 vitamin K Nutrition 0.000 title abstract 4
239000011712 vitamin K Substances 0.000 title abstract 4
150000003721 vitamin K derivatives Chemical class 0.000 title abstract 4
229940046010 vitamin k Drugs 0.000 title abstract 4
210000004204 blood vessel Anatomy 0.000 title abstract 2
230000002308 calcification Effects 0.000 title abstract 2
208000024172 Cardiovascular disease Diseases 0.000 abstract 2
206010019280 Heart failures Diseases 0.000 abstract 2
206010002383 Angina Pectoris Diseases 0.000 abstract 1
206010003210 Arteriosclerosis Diseases 0.000 abstract 1
206010020772 Hypertension Diseases 0.000 abstract 1
208000007177 Left Ventricular Hypertrophy Diseases 0.000 abstract 1
206010024119 Left ventricular failure Diseases 0.000 abstract 1
206010037368 Pulmonary congestion Diseases 0.000 abstract 1
208000034189 Sclerosis Diseases 0.000 abstract 1
230000032683 aging Effects 0.000 abstract 1
208000011775 arteriosclerosis disease Diseases 0.000 abstract 1
210000001367 artery Anatomy 0.000 abstract 1
230000001684 chronic effect Effects 0.000 abstract 1
238000009472 formulation Methods 0.000 abstract 1
239000000203 mixture Substances 0.000 abstract 1
208000010125 myocardial infarction Diseases 0.000 abstract 1
235000016709 nutrition Nutrition 0.000 abstract 1
239000008194 pharmaceutical composition Substances 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
- A61K31/593—9,10-Secocholestane derivatives, e.g. cholecalciferol, i.e. vitamin D3
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/15—Vitamins
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/15—Vitamins
- A23L33/155—Vitamins A or D
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/12—Ketones
- A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
Heart & Thoracic Surgery (AREA)
Food Science & Technology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Cardiology (AREA)
Epidemiology (AREA)
Polymers & Plastics (AREA)
Mycology (AREA)
Nutrition Science (AREA)
Organic Chemistry (AREA)
Urology & Nephrology (AREA)
Vascular Medicine (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

DK06076172.3T 2005-06-03 2006-06-06 Anvendelse af vitamin K for at omvende forkalkning af blodkar DK1728507T4 (da)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US11/144,853 US9364447B2 (en)	2002-08-30	2005-06-03	Compositions for treating or preventing cardiovascular disease

Publications (2)

Publication Number	Publication Date
DK1728507T3 true DK1728507T3 (da)	2011-05-23
DK1728507T4 DK1728507T4 (da)	2015-01-12

Family

ID=36940251

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK06076172.3T DK1728507T4 (da)	2005-06-03	2006-06-06	Anvendelse af vitamin K for at omvende forkalkning af blodkar

Country Status (8)

Country	Link
EP (1)	EP1728507B2 (da)
AT (1)	ATE501715T1 (da)
DE (1)	DE602006020658D1 (da)
DK (1)	DK1728507T4 (da)
ES (1)	ES2363368T5 (da)
PL (1)	PL1728507T3 (da)
PT (1)	PT1728507E (da)
SI (1)	SI1728507T1 (da)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB0220182D0 (en)	2002-08-30	2002-10-09	Cardiovascular Res Inst Maastr	Organic compounds
EP2060256A1 (en)	2007-11-16	2009-05-20	Gnosis S.p.A.	Pharmaceutical and nutraceutical compositions based on menaquinols
DE102010015242A1 (de) *	2010-04-15	2011-10-20	Fresenius Medical Care Deutschland Gmbh	Kombination aus Vitamin K und Nikotinamid
IT1402330B1 (it) *	2010-09-03	2013-08-30	Poli	Integratore alimentare
US11357250B2 (en)	2016-08-15	2022-06-14	Summit Innovation Labs LLC	Treatment and prevention of diabetes and obesity
US11344575B2 (en) *	2016-08-15	2022-05-31	Summit Innovation Labs, LLC	Vascular calcification prevention and treatment
CN111836833B (zh) *	2017-12-14	2023-01-31	卡尔罗伊健康科学公司	通过硫酸化多糖稳定并逆转动脉粥样硬化病变的方法
US11911349B2 (en)	2018-03-30	2024-02-27	Nattopharma As	Rapidly improving vascular conditions by administering vitamin K
MX2020013301A (es)	2018-06-08	2021-05-12	Epizon Pharma Inc	Metodos y composiciones para prevenir o tratar calcifilaxis.
KR20210018423A (ko)	2018-06-08	2021-02-17	에피존 파마 인코포레이티드	조직 석회화의 예방 또는 치료를 위한 방법 및 조성물
BR112021017994A2 (pt) *	2019-03-11	2021-11-16	Kaydence Pharma As	Método para melhorar função cardiovascular, elasticidade, redução de calcificação, pwv e/ou função endotelial, kit, e, composições para uso na melhoria de função cardiovascular, elasticidade, redução de calcificação, pwv e/ou função endotelial, na reversão de calcificação de vasos sanguíneos e no aumento de produção de óxido nítrico endotelial
CN110122866A (zh) *	2019-05-31	2019-08-16	广东双骏生物科技有限公司	一种慢性肾脏病血管钙化的特殊医学用途食品及制备方法
CN114748486A (zh) *	2022-03-25	2022-07-15	南京盛德生物科技研究院有限公司	一种含有维生素k2改善心血管钙化的药物组合物及其制备方法与应用
KR20250019094A (ko)	2022-05-31	2025-02-07	레지온 시드단마크	관상동맥 석회화(cac) 치료용 비타민 k2
CN118416279B (zh) *	2024-04-23	2025-09-02	大连医科大学附属第二医院	一种预防血管钙化的动静脉内瘘外用敷料及其制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0679394B1 (en) †	1994-04-28	1998-01-14	Eisai Co., Ltd.	Menatetronome derivative as antiarteriosclerotic agent
DE60128179T2 (de)	2000-05-12	2008-01-10	Nattopharma Asa	Nahrungsmittel enthaltend Vitamin k2
WO2003013420A2 (en) †	2001-08-03	2003-02-20	Vitak Bv	Isoprenyl derivatives and their use in the treatment and prevention of osteoporosis and cardiovascular calcification
GB0220182D0 (en) †	2002-08-30	2002-10-09	Cardiovascular Res Inst Maastr	Organic compounds

2006
- 2006-06-06 SI SI200631032T patent/SI1728507T1/sl unknown
- 2006-06-06 DK DK06076172.3T patent/DK1728507T4/da active
- 2006-06-06 PL PL06076172T patent/PL1728507T3/pl unknown
- 2006-06-06 PT PT06076172T patent/PT1728507E/pt unknown
- 2006-06-06 ES ES06076172T patent/ES2363368T5/es active Active
- 2006-06-06 AT AT06076172T patent/ATE501715T1/de active
- 2006-06-06 EP EP06076172.3A patent/EP1728507B2/en active Active
- 2006-06-06 DE DE602006020658T patent/DE602006020658D1/de active Active

Also Published As

Publication number	Publication date
PT1728507E (pt)	2011-05-27
DE602006020658D1 (de)	2011-04-28
PL1728507T3 (pl)	2011-09-30
EP1728507B1 (en)	2011-03-16
ES2363368T3 (es)	2011-08-02
ES2363368T5 (es)	2015-03-02
EP1728507A1 (en)	2006-12-06
ATE501715T1 (de)	2011-04-15
EP1728507B2 (en)	2014-11-12
DK1728507T4 (da)	2015-01-12
SI1728507T1 (sl)	2011-07-29

Similar Documents

Publication	Publication Date	Title
GB0220182D0 (en)	2002-10-09	Organic compounds
ES2363368T5 (es)	2015-03-02	Utilización de vitamina K para revertir la calcificación de los vasos sanguíneos
Wood	1958	Aortic stenosis∗
JP2015512387A5 (da)	2016-04-07
CL2008002478A1 (es)	2009-05-15	Compuestos derivados de n-fenil-5-(4 haloalcoxi)fenil) pirimidin-2-amino, inhibidores de c-kit y pdgfr; composicion farmaceutica; y su uso en el tratmiento de asma, dermatitis atopica, hipertension pulmonar o arterial, fibrosis renal, pulmonar o cardiaca, entre otras.
EP2862859A3 (en)	2015-05-06	Compounds, compositions and methods
IL186487A (en)	2012-01-31	Cyclic amines, processes for their preparation, pharmaceutical compositions comprising them and uses thereof
CA2698332A1 (en)	2009-03-12	Pyrazole derivatives as soluble guanylate cyclase activators
NZ716245A (en)	2017-07-28	Fused benzoxazepinones as ion channel modulators
WO2005082863A3 (en)	2005-12-22	1,4 diaryl-dihydropyrimidin-2 ones and their use as a human neutrophil elastase inhibitors
FI3562487T3 (fi)	2023-12-14	Metalloentsyymi-inhibiittoriyhdisteitä
CL2008001205A1 (es)	2008-11-14	Compuestos derivados de biciclo[2.2.2]octeno; composicion farmaceutica que los contiene; y uso en el tratamiento o prevencion de angina cronica estable, hipertension, isquemia renal y cardiaca, arritmias cardiacas, hipertrofia cardiaca y falla congestiva del corazon.
IL286242A (en)	2021-10-31	Rapid improvement in endothelial function, reduction of arterial stiffness and reversal of vascular calcification through the administration of vitamin K
SG162734A1 (en)	2010-07-29	Compositions comprising nebivolol
ATE449600T1 (de)	2009-12-15	Verwendung von glycerin zur verbesserung der herzfunktion
EP4456897A4 (en)	2025-12-10	ORAL FORMULATIONS OF LEVOSIMENDAN FOR THE TREATMENT OF PULMONARY HYPERTENSION WITH HEART FAILURE AND PRESERVED EJECTION FRACTION
Teixeira Filho et al.	2004	Right ventricular aneurysm following right ventricular infarction
AR025645A1 (es)	2002-12-04	Uso de tienopirimidinas
DE602004027515D1 (de)	2010-07-15	Verwendung von Megestrolacetat zur Verbesserung der Herzfunktion und zur Behandlung von Herzinsuffizienz
Chagnon et al.	2005	Comparison between" swan-ganz" derived and echocardiographic variables in the prediction of hemodynamic complications following cardiac surgery
Franklin	2010	The pathobiology of isolated systolic hypertension
Sanchis-Gomar et al.	2015	Long-term strenuous endurance exercise and the right ventricle: Is it a real matter of concern?
Irtyuga et al.	2010	Matrix metalloproteinase activity in patients with ascending aortic aneurysm of different etiology
Çağlar et al.	2015	Coexistence of Ectasia and Myocardial Bridge on the Same Coronary Artery Segment.
RU2004104575A (ru)	2005-07-27	Способ пневмонэктомии